Connect with us

Brilife

$NRXP – NRx Pharmaceuticals The Israel Institute for Biological Research (IIBR) reports at least 80% effectiveness in initial results for their BriLife COVID vaccine which NRx will market worldwide. (@GregLarssen)

Published

on

$NRXP – NRx Pharmaceuticals

The Israel Institute for Biological Research (IIBR) reports at least 80% effectiveness in initial results for their BriLife COVID vaccine which NRx will market worldwide.

timesofisrael.com/tv-israeli-mad…


Source by Greg Larssen

Trending

Copyright © 2021 The COVID Site.